Top 10 Companies in the Pharmaceutical Grade Niacin Market (2026): Market Leaders Shaping Global Health

In Business Insights
September 08, 2026

Global Pharmaceutical Grade Niacin market was valued at USD 80 million in 2023 and is projected to reach USD 110 million by 2030, at a CAGR of 4.2% during the forecast period. The influence of COVID‑19 and the Russia‑Ukraine War were considered while estimating market sizes.

Pharmaceutical Grade Niacin Market – View in Detailed Research Report

The market is underpinned by a steady rise in demand from pharmaceutical manufacturers, driven by the growing use of niacin as a supplement in drug formulations and its role in enhancing product efficacy. The upward trajectory is supported by increasing consumer awareness of vitamin‑rich products and expanding healthcare budgets in emerging economies.

Niacin, a B‑vitamin, is a key metabolic co‑factor that converts food into usable energy and supports nervous, digestive, and dermal health. In the pharmaceutical context, it is incorporated into both prescription drugs and over‑the‑counter supplements, positioning it as a versatile ingredient across multiple downstream applications.

🔟 1. Lonza

Headquarters: Basel, Switzerland
Key Offering: Pharmaceutical‑grade niacin for drug formulation and nutritional supplements

Lonza has long established itself as a leader in specialty chemicals, and its niacin portfolio benefits from a robust R&D pipeline that focuses on purity, bioavailability, and scalable production. The company’s integrated manufacturing network spans North America, Europe, and Asia, enabling it to meet the diverse regulatory and supply‑chain demands of global clients.

Sustainability and Growth Initiatives:

  • Investment in green chemistry processes to reduce solvent usage and waste
  • Partnerships with academic institutions to develop next‑generation vitamin delivery systems
  • Expansion of production capacity in India and China to capture emerging market share

9️⃣ 2. Jubilant Life Sciences

Headquarters: Hyderabad, India
Key Offering: Bulk niacin for pharmaceutical and nutraceutical applications

Jubilant’s strategic focus on cost‑effective manufacturing has positioned it as a preferred supplier in price‑sensitive markets. Its proprietary crystallization technology enhances product purity while keeping production costs low, giving the company a competitive edge in both domestic and export markets.

Sustainability and Growth Initiatives:

  • Implementation of closed‑loop water recycling systems across its plants
  • Launch of a sustainability reporting framework aligned with GRI standards
  • Development of a regional distribution hub in Southeast Asia to reduce lead times

8️⃣ 3. Vertellus

Headquarters: London, United Kingdom
Key Offering: High‑purity niacin for pharmaceutical synthesis

Vertellus has carved out a niche by providing niacin with a purity exceeding 99.9%, which is essential for advanced drug formulations. Its flexible contract manufacturing services allow clients to scale production quickly in response to market demand spikes.

Sustainability and Growth Initiatives:

  • Adoption of renewable energy sources for its UK manufacturing facility
  • Participation in the European Union’s Circular Economy Action Plan
  • Collaboration with biotech firms to co‑develop vitamin‑enriched therapeutic agents

7️⃣ 4. Brother Enterprises

Headquarters: Shanghai, China
Key Offering: Bulk niacin for pharmaceutical and food‑grade applications

Brother Enterprises leverages its extensive distribution network in China to supply niacin to both domestic manufacturers and international importers. The company’s focus on quality assurance and traceability has earned it certifications from ISO 9001 and GMP.

Sustainability and Growth Initiatives:

  • Implementation of digital traceability tools for raw‑material sourcing
  • Investment in waste‑to‑energy projects at its Shanghai plant
  • Strategic alliance with a leading nutraceutical firm to expand product lines

6️⃣ 5. Zhejiang Lanbo Biotechnology

Headquarters: Hangzhou, China
Key Offering: Pharmaceutical‑grade niacin for drug development

Zhejiang Lanbo’s expertise lies in the synthesis of high‑purity niacin derivatives, which are increasingly sought after for specialty drug formulations. Its R&D team focuses on enhancing the solubility of niacin, thereby broadening its therapeutic applications.

Sustainability and Growth Initiatives:

  • Adoption of biodegradable packaging solutions for finished products
  • Collaboration with local universities to foster talent in vitamin chemistry
  • Expansion of its production line to include niacin‑based excipients

5️⃣ 6. Lasons India

Headquarters: Pune, India
Key Offering: Bulk niacin for pharmaceutical and nutritional supplements

Lasons India has positioned itself as a key player in the Indian market by offering cost‑effective niacin solutions that meet stringent quality standards. Its focus on process optimization has resulted in reduced production times and lower carbon footprints.

Sustainability and Growth Initiatives:

  • Deployment of solar power across its manufacturing sites
  • Implementation of a zero‑waste policy in its production processes
  • Strategic partnership with a leading Indian pharmaceutical conglomerate to co‑develop new formulations

4️⃣ 7. Vanetta

Headquarters: Toronto, Canada
Key Offering: High‑purity niacin for specialty pharmaceuticals

Vanetta’s Canadian roots provide a strong foundation in regulatory compliance, enabling it to serve both North American and European clients with confidence. Its advanced purification processes ensure that niacin meets the stringent purity requirements of modern drug products.

Sustainability and Growth Initiatives:

  • Integration of carbon capture technology in its production facilities
  • Participation in the Canada Green Building Council’s sustainability initiatives
  • Investment in digital twins to optimize plant operations

3️⃣ 8. DSM

Headquarters: Heerlen, Netherlands
Key Offering: Pharmaceutical‑grade niacin for drug and supplement markets

DSM’s global footprint and commitment to science drive its position as a trusted supplier of niacin. The company’s focus on innovation has led to the development of niacin formulations with enhanced bioavailability, catering to both prescription and over‑the‑counter markets.

Sustainability and Growth Initiatives:

  • Commitment to net‑zero emissions by 2030 across all manufacturing sites
  • Investment in circular economy projects, including waste‑to‑fuel conversion
  • Collaboration with global health organizations to improve vitamin access in low‑income regions

2️⃣ 9. Tianjin Zhongrui Pharmaceutical

Headquarters: Tianjin, China
Key Offering: Bulk niacin for pharmaceutical and nutraceutical applications

Tianjin Zhongrui’s strength lies in its large‑scale production capacity and stringent quality control protocols. The company has recently expanded its product portfolio to include niacin‑based excipients, enhancing its value proposition to pharmaceutical manufacturers.

Sustainability and Growth Initiatives:

  • Implementation of a comprehensive water‑recycling program
  • Adoption of renewable energy sources for its production facilities
  • Strategic partnership with a leading Chinese pharma group to co‑develop novel vitamin formulations

1️⃣ 10. Resonance Specialties

Headquarters: Austin, Texas, USA
Key Offering: High‑purity niacin for advanced pharmaceutical applications

Resonance Specialties combines cutting‑edge chemistry with a customer‑centric approach. Its niacin products are tailored to meet the exacting standards of biopharmaceutical companies, and the firm’s flexible contract manufacturing services allow for rapid scaling.

Sustainability and Growth Initiatives:

  • Investment in green chemistry initiatives to reduce solvent usage
  • Launch of a sustainability reporting framework aligned with the Science‑Based Targets initiative
  • Expansion of its U.S. manufacturing footprint to support the growing demand from the biopharma sector

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/269867/global-pharmaceutical-grade-niacin-forecast-market-2024-2030-532

Get Full Report: https://www.24chemicalresearch.com/reports/269867/global-pharmaceutical-grade-niacin-forecast-market-2024-2030-532

🌍 Outlook: The Future of Pharmaceutical Grade Niacin

The niacin market is poised for steady expansion, driven by the increasing incorporation of vitamin B‑complexes in drug delivery systems and the rising demand for nutraceuticals. Companies that can align their supply chains with sustainability imperatives and regulatory compliance are likely to capture the most value.

📈 Key Trends Shaping the Market:

  • Growth of high‑purity niacin demand in biopharmaceutical formulations
  • Expansion of global production capacity in Asia and North America
  • Integration of digital supply‑chain solutions for traceability and compliance
  • Increasing focus on green chemistry to reduce environmental impact

These developments underscore the importance of innovation, quality, and sustainability as companies navigate a competitive landscape that is becoming more demanding and regulated.